Advertisement
Review Article| Volume 44, ISSUE 1, P137-157, March 2023

Acute Rejection and Chronic Lung Allograft Dysfunction

Obstructive and Restrictive Allograft Dysfunction
  • Author Footnotes
    1 Contributed equally as first author.
    Hanne Beeckmans
    Footnotes
    1 Contributed equally as first author.
    Affiliations
    Department of Chronic Diseases and Metabolism, KU Leuven, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Leuven, Belgium
    Search for articles by this author
  • Author Footnotes
    1 Contributed equally as first author.
    Saskia Bos
    Footnotes
    1 Contributed equally as first author.
    Affiliations
    Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium

    Newcastle University, Translational and Clinical Research Institute, Newcastle upon Tyne, UK
    Search for articles by this author
  • Author Footnotes
    2 Contributed equally as senior author.
    Robin Vos
    Correspondence
    Corresponding author. Department of Respiratory Diseases, University Hospitals Leuven, 49 Herestraat, Leuven B-3000, Belgium.
    Footnotes
    2 Contributed equally as senior author.
    Affiliations
    Department of Chronic Diseases and Metabolism, KU Leuven, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Leuven, Belgium

    Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium
    Search for articles by this author
  • Author Footnotes
    2 Contributed equally as senior author.
    Allan R. Glanville
    Footnotes
    2 Contributed equally as senior author.
    Affiliations
    Lung Transplant Unit, St. Vincent's Hospital, Sydney, Australia
    Search for articles by this author
  • Author Footnotes
    1 Contributed equally as first author.
    2 Contributed equally as senior author.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Chest Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yusen R.D.
        • Edwards L.B.
        • Kucheryavaya A.Y.
        • et al.
        The Registry of the international Society for heart and lung transplantation: Thirty-second Official adult lung and heart-lung transplantation report--2015; Focus theme: early graft failure.
        J Heart Lung Transpl. 2015; 34: 1264-1277https://doi.org/10.1016/j.healun.2015.08.014
        • Chambers D.C.
        • Cherikh W.S.
        • Harhay M.O.
        • et al.
        The international Thoracic organ transplant Registry of the international Society for heart and lung transplantation: Thirty-sixth adult lung and heart-lung transplantation report-2019; Focus theme: donor and recipient size match.
        J Heart Lung Transpl. 2019; 38: 1042-1055https://doi.org/10.1016/j.healun.2019.08.001
        • Martinu T.
        • Chen D.F.
        • Palmer S.M.
        Acute rejection and humoral sensitization in lung transplant recipients.
        Proc Am Thorac Soc. 2009; 6: 54-65https://doi.org/10.1513/pats.200808-080GO
        • Werlein C.
        • Seidel A.
        • Warnecke G.
        • et al.
        Lung transplant pathology: an overview on current entities and procedures.
        Surg Pathol Clin. 2020; 13: 119-140https://doi.org/10.1016/j.path.2019.11.003
        • Glanville A.R.
        • Verleden G.M.
        • Todd J.L.
        • et al.
        Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT.
        J Heart Lung Transpl. 2019; 38: 483-492https://doi.org/10.1016/j.healun.2019.03.008
        • Verleden G.M.
        • Glanville A.R.
        • Lease E.D.
        • et al.
        Chronic lung allograft dysfunction: definition, diagnostic criteria and approaches to treatment. A consensus report from the pulmonary Council of the ISHLT.
        ISHLT. 2019; 38: 493-503
        • Roden A.C.
        • Aisner D.L.
        • Allen T.C.
        • et al.
        Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies: a perspective from Members of the pulmonary pathology Society.
        Arch Pathol Lab Med. 2017; 141: 437-444https://doi.org/10.5858/arpa.2016-0459-SA
        • Bergantini L.
        • d’Alessandro M.
        • De Vita E.
        • et al.
        Regulatory and effector cell Disequilibrium in patients with acute cellular rejection and chronic lung allograft dysfunction after lung transplantation: comparison of Peripheral and alveolar distribution.
        Cells. 2021; 10: 780https://doi.org/10.3390/cells10040780
        • Levy L.
        • Huszti E.
        • Tikkanen J.
        • et al.
        The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation.
        Am J Transpl. 2020; 20: 241-249https://doi.org/10.1111/ajt.15561
        • Hachem R.R.
        • Khalifah A.P.
        • Chakinala M.M.
        • et al.
        The significance of a single episode of minimal acute rejection after lung transplantation.
        Transplantation. 2005; 80: 1406-1413
        • Yousem S.A.
        Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients.
        Hum Pathol. 1996; 27: 269-273https://doi.org/10.1016/S0046-8177(96)90068-4
        • Kim D.W.
        • Dacic S.
        • Iacono A.
        • et al.
        Significance of a solitary perivascular mononuclear infiltrate in lung allograft recipients with mild acute cellular rejection.
        J Heart Lung Transpl. 2005; 24: 152-155https://doi.org/10.1016/j.healun.2003.10.024
        • Glanville A.R.
        • Aboyoun C.L.
        • Havryk A.
        • et al.
        Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
        Am J Respir Crit Care Med. 2008; 177: 1033-1040https://doi.org/10.1164/rccm.200706-951OC
        • Stewart S.
        • Fishbein M.C.
        • Snell G.I.
        • et al.
        Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.
        J Heart Lung Transpl. 2007; 26: 1229-1242https://doi.org/10.1016/j.healun.2007.10.017
        • Greer M.
        • Werlein C.
        • Jonigk D.
        Surveillance for acute cellular rejection after lung transplantation.
        Ann Transl Med. 2020; 8: 410https://doi.org/10.21037/atm.2020.02.127
        • Hasegawa T.
        • Iacono A.T.
        • Yousem S.A.
        The anatomic distribution of acute cellular rejection in the allograft lung.
        Ann Thorac Surg. 2000; 69: 1529-1531https://doi.org/10.1016/s0003-4975(00)01226-1
        • Jaksch P.
        • Scheed A.
        • Geleff S.
        • et al.
        Transbronchial lung biopsy after lung transplantation: different A and B scores in different lobes.
        Eur Respir J. 2011; 38 (Available at:) (Accessed February 24, 2022)
        • Arcasoy S.M.
        • Berry G.
        • Marboe C.C.
        • et al.
        Pathologic interpretation of transbronchial biopsy for acute rejection of lung allograft is highly variable.
        Am J Transpl. 2011; 11: 320-328https://doi.org/10.1111/j.1600-6143.2010.03382.x
        • Chakinala M.M.
        • Ritter J.
        • Gage B.F.
        • et al.
        Reliability for grading acute rejection and airway inflammation after lung transplantation.
        J Heart Lung Transpl. 2005; 24: 652-657https://doi.org/10.1016/j.healun.2004.04.002
        • Stephenson A.
        • Flint J.
        • English J.
        • et al.
        Interpretation of transbronchial lung biopsies from lung transplant recipients: inter- and intraobserver agreement.
        Can Respir J. 2005; 12: 75-77https://doi.org/10.1155/2005/483172
        • Burton C.M.
        • Iversen M.
        • Scheike T.
        • et al.
        Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies.
        Transplantation. 2008; 85: 547-553https://doi.org/10.1097/TP.0b013e3181641df9
        • Chakinala M.M.
        • Ritter J.
        • Gage B.F.
        • et al.
        Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation.
        J Heart Lung Transpl. 2004; 23: 1396-1404https://doi.org/10.1016/j.healun.2003.09.018
        • Hopkins P.M.
        • Aboyoun C.L.
        • Chhajed P.N.
        • et al.
        Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis.
        Am J Respir Crit Care Med. 2004; 170: 1022-1026https://doi.org/10.1164/rccm.200302-165OC
        • Khalifah A.P.
        • Hachem R.R.
        • Chakinala M.M.
        • et al.
        Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome.
        Am J Transpl. 2005; 5: 2022-2030https://doi.org/10.1111/j.1600-6143.2005.00953.x
        • Burton C.M.
        • Iversen M.
        • Scheike T.
        • et al.
        Is lymphocytic bronchiolitis a marker of acute rejection? An analysis of 2,697 transbronchial biopsies after lung transplantation.
        J Heart Lung Transpl. 2008; 27: 1128-1134https://doi.org/10.1016/j.healun.2008.06.014
        • Levine D.J.
        • Glanville A.R.
        • Aboyoun C.
        • et al.
        Antibody-mediated rejection of the lung: a consensus report of the international Society for heart and lung transplantation.
        J Heart Lung Transpl. 2016; 35: 397-406https://doi.org/10.1016/j.healun.2016.01.1223
        • Loupy A.
        • Haas M.
        • Roufosse C.
        • et al.
        The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection.
        Am J Transpl. 2020; 20: 2318-2331https://doi.org/10.1111/ajt.15898
        • Matignon M.
        • Muthukumar T.
        • Seshan S.V.
        • et al.
        Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
        Transplantation. 2012; 94: 603-611https://doi.org/10.1097/TP.0b013e31825def05
        • Willicombe M.
        • Roufosse C.
        • Brookes P.
        • et al.
        Acute cellular rejection: impact of donor-specific antibodies and C4d.
        Transplantation. 2014; 97: 433-439https://doi.org/10.1097/01.TP.0000437431.97108.8f
        • Verleden S.E.
        • Von Der Thüsen J.
        • Van Herck A.
        • et al.
        Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: a single-center study.
        Clin Transpl. 2020; 34: e13781https://doi.org/10.1111/ctr.13781
        • Verleden G.M.
        • Raghu G.
        • Meyer K.C.
        • et al.
        A new classification system for chronic lung allograft dysfunction.
        J Heart Lung Transpl. 2014; 33: 127-133https://doi.org/10.1016/j.healun.2013.10.022
        • Byrne D.
        • Nador R.G.
        • English J.C.
        • et al.
        Chronic lung allograft dysfunction: review of CT and pathologic findings.
        Radiol Cardiothorac Imaging. 2021; 3: e200314https://doi.org/10.1148/ryct.2021200314
        • Brun A.L.
        • Chabi M.L.
        • Picard C.
        • et al.
        Lung transplantation: CT assessment of chronic lung allograft dysfunction (CLAD).
        Diagnostics (Basel). 2021; 11: 817https://doi.org/10.3390/diagnostics11050817
        • Verleden S.E.
        • Ruttens D.
        • Vandermeulen E.
        • et al.
        Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?.
        Transplantation. 2013; 95: 1167-1172https://doi.org/10.1097/TP.0b013e318286e076
        • Davis W.A.
        • Finlen Copeland C.A.
        • Todd J.L.
        • et al.
        Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation.
        Am J Transpl. 2012; 12: 745-752https://doi.org/10.1111/j.1600-6143.2011.03849.x
        • Snyder L.D.
        • Wang Z.
        • Chen D.F.
        • et al.
        Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.
        Chest. 2013; 144: 226-233https://doi.org/10.1378/chest.12-0587
        • Verleden S.E.
        • Vanaudenaerde B.M.
        • Emonds M.P.
        • et al.
        Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.
        Eur Respir J. 2017; 50https://doi.org/10.1183/13993003.01248-2017
        • Muynck B.D.
        • Herck A.V.
        • Sacreas A.
        • et al.
        Successful Pseudomonas aeruginosa eradication improves outcomes after lung transplantation: a retrospective cohort analysis.
        Eur Respir J. 2020; https://doi.org/10.1183/13993003.01720-2020
        • Weigt S.S.
        • Copeland C.A.F.
        • Derhovanessian A.
        • et al.
        Colonization with small Conidia Aspergillus Species is associated with bronchiolitis obliterans syndrome: a two-center validation study.
        Am J Transplant. 2013; 13: 919-927https://doi.org/10.1111/ajt.12131
        • Moore C.A.
        • Pilewski J.M.
        • Venkataramanan R.
        • et al.
        Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
        Transpl Infect Dis. 2017; 19https://doi.org/10.1111/tid.12688
        • Le Pavec J.
        • Pradère P.
        • Gigandon A.
        • et al.
        Risk of lung allograft dysfunction associated with Aspergillus infection.
        Transpl Direct. 2021; 7: e675https://doi.org/10.1097/TXD.0000000000001128
        • Allyn P.R.
        • Duffy E.L.
        • Humphries R.M.
        • et al.
        Graft loss and CLAD-onset is Hastened by viral pneumonia after lung transplantation.
        Transplantation. 2016; 100: 2424-2431https://doi.org/10.1097/TP.0000000000001346
        • Hartwig M.G.
        • Anderson D.J.
        • Onaitis M.W.
        • et al.
        Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux.
        Ann Thorac Surg. 2011; 92 (discussion; 468-469): 462-468https://doi.org/10.1016/j.athoracsur.2011.04.035
        • Ruttens D.
        • Verleden S.E.
        • Bijnens E.M.
        • et al.
        An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe.
        Eur Respir J. 2017; 49: 1600484https://doi.org/10.1183/13993003.00484-2016
        • Huang H.J.
        • Yusen R.D.
        • Meyers B.F.
        • et al.
        Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome.
        Am J Transpl. 2008; 8: 2454-2462https://doi.org/10.1111/j.1600-6143.2008.02389.x
        • Sarma N.J.
        • Tiriveedhi V.
        • Angaswamy N.
        • et al.
        Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.
        Hum Immunol. 2012; 73: 1275-1281https://doi.org/10.1016/j.humimm.2012.06.014
        • Koutsokera A.
        • Royer P.J.
        • Antonietti J.P.
        • et al.
        Development of a Multivariate Prediction model for early-onset bronchiolitis obliterans syndrome and restrictive allograft syndrome in lung transplantation.
        Front Med (Lausanne). 2017; 4: 109https://doi.org/10.3389/fmed.2017.00109
        • Paraskeva M.
        • Bailey M.
        • Levvey B.J.
        • et al.
        Cytomegalovirus Replication within the lung allograft is associated with bronchiolitis obliterans syndrome.
        Am J Transplant. 2011; 11: 2190-2196https://doi.org/10.1111/j.1600-6143.2011.03663.x
        • Sato M.
        Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?.
        Ann Transl Med. 2020; 8: 418https://doi.org/10.21037/atm.2020.02.159
        • Vanstapel A.
        • Verleden S.E.
        • Verbeken E.K.
        • et al.
        Beyond bronchiolitis obliterans: in-depth histopathologic characterization of bronchiolitis obliterans syndrome after lung transplantation.
        J Clin Med. 2021; 11: 111https://doi.org/10.3390/jcm11010111
        • Verleden S.E.
        • Von der Thüsen J.
        • Roux A.
        • et al.
        When tissue is the issue: a histological review of chronic lung allograft dysfunction.
        Am J Transpl. 2020; 20: 2644-2651https://doi.org/10.1111/ajt.15864
        • Meyer K.C.
        • Raghu G.
        • Verleden G.M.
        • et al.
        An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.
        Eur Respir J. 2014; 44: 1479-1503https://doi.org/10.1183/09031936.00107514
        • Agusti A.
        • Barnes N.
        • Cruz A.A.
        • et al.
        Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
        Respir Med. 2021; 187: 106572https://doi.org/10.1016/j.rmed.2021.106572
        • Qin R.
        • An J.
        • Xie J.
        • et al.
        FEF25-75% is a more sensitive measure reflecting airway dysfunction in patients with Asthma: a comparison study using FEF25-75% and FEV1.
        J Allergy Clin Immunol Pract. 2021; 9 (e6): 3649-3659https://doi.org/10.1016/j.jaip.2021.06.027
        • Estenne M.
        • Maurer J.R.
        • Boehler A.
        • et al.
        Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.
        J Heart Lung Transplant. 2002; 21: 297-310https://doi.org/10.1016/S1053-2498(02)00398-4
        • Darley D.R.
        • Ma J.
        • Huszti E.
        • et al.
        Diffusing capacity for carbon monoxide (DLCO): association with long-term outcomes after lung transplantation in a 20-year longitudinal study.
        Eur Respir J. 2021; 25: 2003639https://doi.org/10.1183/13993003.03639-2020
        • Hildebrandt J.
        • Rahn A.
        • Kessler A.
        • et al.
        Lung clearance index and diffusion capacity for CO to detect early functional pulmonary impairment in children with rheumatic diseases.
        Pediatr Rheumatol Online J. 2021; 19: 23https://doi.org/10.1186/s12969-021-00509-1
        • Winkler A.
        • Kahnert K.
        • Behr J.
        • et al.
        Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.
        Respir Res. 2018; 19: 171https://doi.org/10.1186/s12931-018-0881-1
        • Stanojevic S.
        • Bowerman C.
        • Robinson P.
        Multiple breath washout: measuring early manifestations of lung pathology.
        Breathe. 2021; 17: 210016https://doi.org/10.1183/20734735.0016-2021
        • Driskel M.
        • Horsley A.
        • Fretwell L.
        • et al.
        Lung clearance index in detection of post-transplant bronchiolitis obliterans syndrome.
        ERJ Open Res. 2019; 5: 00164-02019https://doi.org/10.1183/23120541.00164-2019
        • Nyilas S.
        • Carlens J.
        • Price T.
        • et al.
        Multiple breath washout in pediatric patients after lung transplantation.
        Am J Transpl. 2018; 18: 145-153https://doi.org/10.1111/ajt.14432
        • Kaminsky D.A.
        • Simpson S.J.
        • Berger K.I.
        • et al.
        Clinical significance and applications of oscillometry.
        Eur Respir Rev. 2022; 31: 210208https://doi.org/10.1183/16000617.0208-2021
        • Cho E.
        • Wu J.K.Y.
        • Birriel D.C.
        • et al.
        Airway oscillometry detects Spirometric-silent episodes of acute cellular rejection.
        Am J Respir Crit Care Med. 2020; 201: 1536-1544https://doi.org/10.1164/rccm.201908-1539OC
        • Ochman M.
        • Wojarski J.
        • Wiórek A.
        • et al.
        Usefulness of the impulse oscillometry system in graft function Monitoring in lung transplant recipients.
        Transpl Proc. 2018; 50: 2070-2074https://doi.org/10.1016/j.transproceed.2017.12.060
        • Bos S.
        • Beeckmans H.
        • Vanstapel A.
        • et al.
        Pulmonary graft-versus-host disease and chronic lung allograft dysfunction: two sides of the same coin?.
        Lancet Respir Med. 2022; 10: 796-810https://doi.org/10.1016/S2213-2600(22)00001-7

      References (Appendix)

        • Burton C.M.
        • Iversen M.
        • Scheike T.
        • et al.
        Is lymphocytic bronchiolitis a marker of acute rejection? An analysis of 2,697 transbronchial biopsies after lung transplantation.
        J Heart Lung Transplant. 2008; 27: 1128-1134
        • Glanville A.R.
        • Aboyoun C.L.
        • Havryk A.
        • et al.
        Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
        Am J Respir Crit Care Med. 2008; 177: 1033-1040https://doi.org/10.1164/rccm.200706-951OC
        • Burton C.M.
        • Iversen M.
        • Scheike T.
        • et al.
        Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies.
        Transplantation. 2008; 85: 547-553https://doi.org/10.1097/TP.0b013e3181641df9
        • Hachem R.R.
        • Khalifah A.P.
        • Chakinala M.M.
        • et al.
        The significance of a single episode of minimal acute rejection after lung transplantation.
        Transplantation. 2005; 80: 1406-1413https://doi.org/10.1097/01.tp.0000181161.60638.fa
        • Sibley R.K.
        • Berry G.J.
        • Tazelaar H.D.
        • et al.
        The role of transbronchial biopsies in the management of lung transplant recipients.
        J Heart Lung Transplant. 1993; 12 (doi: not available): 308-324
        • Scott J.P.
        • Fradet G.
        • Smyth R.L.
        • et al.
        Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients.
        J Heart Lung Transplant. 1991; 10 ([discussion: 636-7]): 626-636